For citations:
Bordin D.S., Voynovan I.N., Kolbasnikov S.V. EVIDENCE BASE OF LACTOBACILLUS REUTERI EFFI CACY IN THE TREATMENT OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI. Experimental and Clinical Gastroenterology. 2016;(8):82-87. (In Russ.)
Fullscreen
Popular articles
No 12 (2020)
No 1 (2023)
No 6 (2020)
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Authors
Keywords
COVID-19
Crohn’s disease
Helicobacter pylori
arterial hypertension
celiac disease
children
chronic pancreatitis
comorbidity
diagnosis
gastroesophageal reflux disease
inflammatory bowel disease
insulin resistance
irritable bowel syndrome
liver
metabolic syndrome
microbiota
non-alcoholic fatty liver disease
obesity
probiotics
treatment
ulcerative colitis
Chechulina str. 6-42, Moscow, Russia, 105568
tel.: +79175619505
e-mail: ECGarticle@gmail.com
